Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 7/2/2025

Antibiotic Use in Multiple Sclerosis Patients

Introduction to Fluoroquinolone Risks

  • Patients with Multiple Sclerosis should avoid levofloxacin due to potential neurological adverse effects that could exacerbate MS symptoms 1
  • Levofloxacin can cause neurologic effects including dizziness, insomnia, tremulousness, and headache in approximately 0.5% of patients 1

Alternative Antibiotics for MS Patients

  • For respiratory infections, consider macrolides, beta-lactams, or cephalosporins as alternative antibiotics 1
  • For urinary tract infections, consider nitrofurantoin, trimethoprim-sulfamethoxazole, fosfomycin, or cephalosporins as alternative antibiotics 1
  • For skin/soft tissue infections, consider beta-lactams, clindamycin, or cephalosporins as alternative antibiotics 1

Considerations for Antibiotic Selection

  • When selecting antibiotics for MS patients, consider disease-modifying therapies (DMTs) that may affect immune response or interact with certain antibiotics 2
  • Close monitoring for neurological symptoms during antibiotic treatment is essential 2

General Principles for Antibiotic Use in MS Patients

  • Avoid assuming all antibiotics have equal risk, as fluoroquinolones pose specific neurological risks that other classes don't 1
  • Don't delay necessary treatment, but consider the risk-benefit ratio and alternative antibiotics when possible 1
  • Be aware of drug interactions between MS medications and certain antibiotics, requiring dose adjustments or alternative selections 2